why choose us

300×250 Ad Slot

Research Article: Impact of sodium-glucose cotransporter-2 inhibitor use on peak VO2 in advanced heart failure patients

Date Published: 2024-07-24

Abstract:
Introduction: Advanced heart failure (HF) is an epidemic that affects multiple organ systems with high morbidity and mortality rates despite optimal medical therapy (OMT) and remains the leading cause of hospitalizations in type 2 diabetes-related cardiovascular disease. The addition of sodium-glucose co-transporter inhibitors (SGLT2i) in treating these patients has seen improved mortality and hospital admission rates. As such, we felt it was important to investigate whether the use of SGLT2i improved functional capacity in patients with HF when compared to OMT by evaluating maximum oxygen consumption (peak VO2) using cardiopulmonary exercise testing (CPET).

No summary available.

300×250 Ad Slot